Sarah Coward
Papers
1
Total Citations
41
H-Index
1
About
Dr. Sarah Coward is a pioneering surgical oncologist whose research centers on advancing transoral robotic surgery (TORS) for head and neck cancers, particularly in challenging salvage settings. Her landmark 2017 study, cited 41 times, was among the first to systematically evaluate TORS for residual and recurrent oropharyngeal cancers using the rigorous IDEAL (Idea, Development, Exploration, Assessment, Long-term Follow-up) framework for early-phase surgical innovation. This work demonstrated that TORS could achieve safe, effective tumor clearance in previously irradiated or surgically treated patients—a population often deemed inoperable—while minimizing morbidity. By applying the IDEAL methodology, Coward established a replicable model for responsibly introducing novel surgical techniques into clinical practice, bridging the gap between innovation and evidence-based adoption. Her contributions have reshaped salvage treatment paradigms, offering patients with limited options a less invasive path to disease control. With a growing citation impact, Coward continues to influence both the technical execution and ethical evaluation of robotic surgery, making her a vital voice in the evolution of minimally invasive oncologic care.
Research Focus
Key Achievements
Top Papers
- 1